Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study-Reference-Cited by-同舟云学术

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study

Published:2009-04 Issue:4 Volume:11 Page:379-386
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Blicklé J-F.,Hancu N.,Piletic M.,Profozic V.,Shestakova M.,Dain M-P.,Jacqueminet S.,Grimaldi A.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2008.00980.x/fullpdf

Reference20 articles.

1. Type 2 diabetes: an overview;Lebovitz;Clin Chem,1999

2. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetologia,2006

3. A review of basal insulins;Barnett;Diabet Med,2003

4. The burden of treatment failure in type 2 diabetes;Brown;Diabetes Care,2004

5. 5 CFDC. National diabetes fact sheet, United States, 2005. Available from. http://wwwcdcgov/diabetes/pubs/factsheet05htm. Accessed August 2007.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Fasting Plasma Glucose Titration Target on the Success of Basal Insulin Titration in Insulin-Naïve Patients with Type 2 Diabetes: A Systematic Analysis;Journal of Diabetes Research;2022-07-30

2. An Efficacy and Safety Study of Remogliflozin in Obese Indian Type 2 Diabetes Mellitus Patients Who Were Inadequately Controlled on Insulin Glargine Plus other Oral Hypoglycemic Agents;Current Diabetes Reviews;2021-09

3. Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies;Diabetes Research and Clinical Practice;2021-06

4. Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice;Diabetes Spectrum;2019-05-01

5. Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States;Diabetes Therapy;2018-02-06